Orange Book product · Generic (ANDA)
ALLOPURINOL
ALLOPURINOL
At a glance
Aug 03, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 03, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
ALLOPURINOL
Strength
100MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 217748
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ALLOPURINOL
- 1984ALLOPURINOLBrand (NDA)
NDA 018241 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018785 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018832 · WATSON LABS
- 1984ALLOPURINOLBrand (NDA)
NDA 018877 · WATSON LABS
- —LOPURINBrand (NDA)
NDA 018297 · ABBOTT
- —ZYLOPRIMBrand (NDA)
NDA 016084 · CASPER PHARMA LLC
- 2025ALLOPURINOLGeneric (ANDA)
ANDA 215091 · AUROBINDO PHARMA LTD
- 2023ALLOPURINOLGeneric (ANDA)
ANDA 211807 · LUPIN
- 2022ALLOPURINOLGeneric (ANDA)
ANDA 214443 · HARMAN FINOCHEM
- 2019ALLOPURINOLGeneric (ANDA)
ANDA 211820 · UNICHEM
- 2017ALLOPURINOLGeneric (ANDA)
ANDA 210117 · ZYDUS PHARMS
- 2016ALLOPURINOLGeneric (ANDA)
ANDA 204467 · REGCON HOLDINGS
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
